| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
7,738 |
7,228 |
$735K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,768 |
4,296 |
$82K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,692 |
2,185 |
$30K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
24 |
24 |
$3K |
| 20610 |
|
55 |
55 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
210 |
204 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
37 |
33 |
$721.23 |
| 87428 |
|
28 |
28 |
$259.92 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
13 |
13 |
$90.71 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
142 |
125 |
$75.81 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
25 |
25 |
$34.71 |
| 3074F |
|
309 |
298 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
19 |
19 |
$0.00 |
| 3079F |
|
24 |
24 |
$0.00 |
| 0011A |
|
12 |
12 |
$0.00 |
| 3078F |
|
294 |
284 |
$0.00 |